The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon - Visser, LE; van Vliet, M; van Schaik, RH (Pharmacogenetics, 2004)
et al.